Daniel M. Geynisman, MD, on Optimal Therapy Selection in RCCByDaniel M. Geynisman, MDMarch 11th 2022At 2022 ASCO GU, Daniel M. Geynisman, MD, spoke with CancerNetwork® about his strategy for treating renal cell carcinoma across lines of therapy.